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Abstract
Controversy exists over whether the predominant cell death of hepatocytes is due to apoptosis
or necrosis after ischemia/reperfusion injury. In this study we investigated the predominant cell
death of hepatocytes after cold ischemia/reperfusion injury using the Annexin V-based assay, and
evaluated the anti-apoptotic effect of ascorbic acid 2-glucoside (AA-2G) added to the University of
Wisconsin solution (UW solution) in rat liver transplantation. The retrieved liver was preserved in
4 UW solution for 24 h, and then transplanted orthotopically to the syngeneic Wistar recipient. The
animals were divided into 2 groups, a control group (n=10), in which liver grafts were preserved in
UW solution (4), and an AA-2G group (n=10), in which liver grafts were preserved in UW solution
(4) with AA-2G (100 ug/ml). The serum AST level 4 h after reperfusion in the control group was
significantly suppressed in the AA-2G group, and the bile production of the liver graft in the AA-
2G group was well recovered. The mean survival time in the AA-2G group was significantly
improved compared with that in the control group. Annexin-V and Propidium iodide staining
4 h after reperfusion showed a significantly higher percentage of viable hepatocytes in the AA-
2G group compared with the control group (93.4 +/- 2.0 vs. 80.3 +- 2.1%, P<0.05). In the
control group, the main cell death of hepatocytes was apoptosis (early apoptosis: 10.0 +- 4.7%,
late apoptosis: 6.4 +/- 1.7%). The addition of AA-2G to the UW solution significantly inhibited
both early and late apoptotic cell death 4 h after reperfusion (early apoptosis: 0.98 +/- 0.88%, late
apoptosis: 2.2 +/- 1.1%). The expression of caspase 9 in the immunostaining of the liver graft was
suppressed in the AA-2G group compared with in the control group. Our study using the Annexin
V-based assay provided evidence that the predominant cell death of hepatocytes was apoptosis
after 24 h cold ischemia/reperfusion injury in rat liver transplantation. The addition of AA-2G to
the UW solution attenuated 24 h cold ischemia/reperfusion injury by inhibiting the apoptosis of
hepatocytes.
KEYWORDS: apoptosis, ischemia/ reperfusion injury, liver transplantation, ascorbic acid 2-
glucoside(AA-2G)
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Controversy exists over whether the predominant cell death of hepatocytes is due to apoptosis or necrosis after ischemia/reperfusion injury. In this study we investigated the predominant cell death of hepatocytes after cold ischemia/reperfusion injury using the Annexin V-based assay, and evaluated the anti-apoptotic eﬀect of ascorbic acid 2-glucoside(AA-2G)added to the University of Wisconsin solution (UW solution)in rat liver transplantation. The retrieved liver was preserved in 4°C UW solution for 24 h, and then transplanted orthotopically to the syngeneic Wistar recipient.
The animals were divided into 2 groups, a control group (n＝10), in which liver grafts were preserved in UW solution (4°C), and an AA-2G group(n＝10), in which liver grafts were preserved in UW solution (4°C)with AA-2G (100 ug/ml). The serum AST level 4 h after reperfusion in the control group was signiﬁcantly suppressed in the AA-2G group, and the bile production of the liver graft in the AA-2G group was well recovered. The mean survival time in the AA-2G group was signiﬁcantly improved compared with that in the control group. Annexin-V and Propidium iodide staining 4 h after reperfusion showed a signiﬁcantly higher percentage of viable hepatocytes in the AA-2G group compared with the control group (93.4±2.0 vs.80.3±2.1 , P＜0.05). In the control group, the main cell death of hepatocytes was apoptosis (early apoptosis:10.0±4.7 , late apoptosis:6.4±1.7 ). The addition of AA-2G to the UW solution signiﬁcantly inhibited both early and late apoptotic cell death 4 h after reperfusion (early apoptosis:0.98±0.88 , late apoptosis:
2.2±1.1 ). The expression of caspase 9 in the immunostaining of the liver graft was suppressed in the AA-2G group compared with in the control group. Our study using the Annexin V-based assay provided evidence that the predominant cell death of hepatocytes was apoptosis after 24 h cold ischemia/reperfusion injury in rat liver transplantation. The addition of AA-2G to the UW solution attenuated 24 h cold ischemia/reperfusion injury by inhibiting the apoptosis of hepatocytes.
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I t has been reported in a clinical setting that an ischemia/reperfusion (I/R) injury reduces liver graft viability due to direct damage to the graft and the susceptibility of the patient to acute rejection［1-3］.
Together with other factors, such as intracellular calcium and the calpain and tumor necrosis factor, the reactive oxygen species (ROS) has been reported to play an important role in the pathogenesis of I/R injury［4-6］.
ROS can damage the membranes via lipid peroxidation,
leading to mitochondrial swelling and cell necrosis［7］,
and can also damage DNA and the fragmentation of the double-strand chromatin, resulting in apoptosis［8, 9］.
With regards to hepatocellular damage after I/R injury, it was reported that ROS can initiate the cascades of both necrosis and apoptosis［10］. Therefore, it is still impor-
tant to protect against ROS-mediated damage induced by I/R injury using free radical scavengers.
There is controversy over whether the predominant cell death of hepatocytes after I/R injury is apoptosis or necrosis. Several laboratories reported, using terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling(TUNEL)assay［11, 12］, that 50 to 70 of endothelial cells(SEC)and 40  to 60  of hepatocytes undergo apoptosis during reperfusion. In human liver transplantation, a high percentage of apoptotic he-
patocytes have also been detected in biopsy specimens
［13］. In contrast, Gujral et al.reported that only a small minority of SEC and hepatocytes undergo apoptosis after warm I/R injury, using the Annexin V-based assay［14］.
This controversy might be inﬂuenced by the sensitivity of the methods used to detect apoptosis. Because the Annexin V-assay is the most sensitive technique to detect ongoing apoptosis［15］, we investigated the predominant cell death of hepatocytes after 24 h cold ischemia(UW solution)/reperfusion injury in rat liver transplantation,
using the Annexin V-based assay.
It has been demonstrated that Ascorbic acid(AA)has ROS scavenging activity not only by protecting the membrane phospholipids against the peroxidative damage of ROS, but also by suppressing ROS production of the membranes［16, 17］. However, the fact that AA is unstable for easy oxidation in the body is a disadvantage,
and AA also cannot be synthesized in the body. Ascorbic acid 2-glucoside(AA-2G)was found to be a promising AA derivative. AA-2G has two beneﬁcial properties;it has high stability against thermal and oxidative degrada-
tion, and it can be rapidly converted to AA byα-
glucosidase in the blood and liver cells［18-20］. There-
fore, in this study, we added AA-2G into the UW solution in order to reduce cold I/R injury caused by liver transplantation.
In this study, we investigated the predominant cell death of hepatocytes after cold ischemia/reperfusion injury using the Annexin V-based assay, and also evaluat-
ed the anti-apoptotic eﬀect of AA-2G added to UW solution in rat liver transplantation.
Materials and Methods
 
All experiments were performed in accordance with the national guidelines for the care and use of laboratory animal and in accordance with the local ethics committee. Male Wistar rat weighing 230-260 g were purchased from Shimizu Laboratory
(Shimizu Supplies Co., Ltd., Hamamatsu, Japan). The rats were allowed free access to food and water before,
during, and after the transplantation. The animal room was windowless with temperatures maintained at (22±2
°C), and was kept under constant environmental condi-
tions with a 12-h light-dark cycle(light, 7AM-7PM). All of the steps of the experiment, including the surgeries,
were performed under sterile conditions.
The experimental ani-
mals were divided into the following two groups according to the preservation procedure used for the retrieved liver graft:control group (n＝10);the liver grafts were preserved in UW solution(4°C)for 24 h;AA-2G group
(n＝10);the liver grafts were preserved for 24 h in UW solution (4°C)with AA-2G (100 ug/ml) (from Haya-
shibara Biochemical Research Institute Co., Ltd.,
Okayama, Japan).
The donor liver procurements were performed according to the standard microsurgical techniques for rat liver transplantation. Brieﬂy, the animals were anesthetized with ether, and the abdomen was opened through a transverse incision. The liver was freed from its ligaments with minimal manipulation and the portal vein and vena cava were divided. A catheter was inserted into the portal vein, and the livers were then ﬂushed in situ with 10 ml of 4°C UW solution or UW solution containing AA-2G, while the supra-and intra-
hepatic vena cava were transected for venting the ﬂushing solution. The liver grafts in each group were preserved for 24 h in a computer-programmed incubater(MIR-151,
Sanyo Co., Ltd., Tokyo, Japan)at 3.9±0.1°C. After
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cold preservation for 24 h, the liver grafts were trans-
planted orthotopically using the Kamada technique［21］.
The bile production in the liver graft was measured as an index of the liver graft function at 4 h after reperfusion. Blood samples were taken at 4 h after reperfusion, and the serum levels of aspartate amino transferase(AST)was measured. Liver biopsies were obtained after cold preservation for 24 h for hematoxylin and eosin(HE)staining. The recipients were sacriﬁced at 4 h after reperfusion for HE staining and Annexin-V assay of the liver grafts.
Ten animals in each group were used for the assessment of survival time.
Annexin V is a 35-to 36-kD calcium-dependent, phospholipid binding protein that has a high aﬃnity for phosphotidyl serine and binds to cells with exposed phosphotidyl serine［15］. Because the membrane phospholipid phosphotidyl serine is translocat-
ed from the inner to the outer leaﬂet of the plasma membrane at an early stage of apoptosis, an Annexin-V assay can identify apoptosis at an earlier stage than the TUNEL assays based on nuclear changes such as DNA fragmentation［14, 15, 22］. In addition, Annexin-V is conjugated to ﬂuorochrome FITC that served as a sensi-
tive probe for ﬂow cytometric analysis in this Annexin-V assay. The Annexin-V assay was carried out in conjunc-
tion with vital dye Propidium iodide(PI)staining in order to distinguish between apoptosis and necrosis, because PI staining can detect DNA that has leaked from the necrotic cell. To detect apoptotic and viable cells, the recipients were sacriﬁced, and the liver tissues were taken at 4 h after reperfusion from each group (n＝5). The hepatocytes were isolated by gently pressing the livers collected, and by then ﬁltering the cells collected through a 70-μm mesh ﬁlter. The cells were washed in cold PBS solution of 4°C, and were sedimented at 1500 Xg for 5 min 3 times. The viable hepatocytes exceeded 95 , as judged by trypan blue exclusion in the normal liver.
About 10?hepatocytes were incubated in 10 ul of FITC-
conjugated Annexin-V (10 ug/ml, Bender Medsystems Diagnostics GmbH, Vienna, Austria)for 15 min, and in PI (50 ug/ml in PBS)on ice for 1 min in the dark. The ﬂuorescence was measured immediately by ﬂow cytometry with FACScan (Beckton Dickinson, San Jose, CA,
USA). At least 10,000 hepatocytes were examined.
Analysis gates were set to exclude endothelial cells that
 
were acquired concurrently with the hepatocytes collec-
tion.
At 4 h after reperfusion, the livers were excised,
and the tissues were immediately cryopreserved. Five
μm sections were prepared and were ﬁxed with 99.5 acetone for 10 min. After being washed 3 times for 5 min with TBST(DW 900 ml, TBS 100 ml, 1 TritonX-100 1 ml), the activity of the endogenous peroxidase was blocked by 0.3  H?O?in methanol for 30 min at room temperature. After 3 rinses in TBST, the sections were incubated with 150μl normal blocking serum for 20 min at room temperature. Hundred fiftyμl of cleaved caspase-9 antibody(Cell Signaling Technology, Beverly,
MA, USA) was added to the samples, which were incubated at 4°C overnight. The sections were incubated on the next day for 30 min with diluted biotinylation secondary antibody solution (Vector Laboratories Inc.,
Burlingame, CA, USA). After being washed 3 times for 5 min each with TBST solution, the sections were in-
cubated for 30 min with ABC reagent at room tempera-
ture. Each section was then incubated in peroxidase substrate solution until the desired stain intensity devel-
oped at room temperature. Each section was then examined by light microscopy at 200 x magniﬁcation.
All values are expressed as mean±SD. The results were analyzed using the Student-t test. P values less than 0.05 were considered to indicate statistical signiﬁcance.
Results
 
The graft liver of the control group had decreased bile produc-
tion (6.1±1.6 ml/h/100 g liver), whereas the AA-2G group had signiﬁcantly improved bile production(10.8±
2.8 ml/h/100 g liver, P＜0.05, Fig. 1). The increase of AST levels 4 h after I/R injury in the AA-2G group were signiﬁcantly suppressed compared with those in the con-
trol group(4292±1401 vs.6944±2143 IU/L,P＜0.05,
Fig.2).
Microvesicular vacuolation in the cytoplasm of the hepatocytes were observed in the control group (Fig. 3A). In contrast,
these vacuolations were not prominent in the AA-2G group(Fig. 3B).
Table 1 shows the recipient survival time of the 2 groups. The mean survival time in
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 the AA-2G group was 28.0±18.5 days, which was signiﬁcantly longer than in the control group(10.9±7.5 days)(P＜0.001).
We used Annexin V and PI staining to verify the percentage of viable, early, and late apoptotic and necrotic hepatocytes after 24 h cold preservation and 4 h reperfusion in rat liver transplantation. Fig. 4 dis-
plays a representative ﬂow cytometric result. The viable hepatocytes were negative for both Annexin V and PI
(Quadrant 1). The cells that were Annexin-V positive,
Fig.1  At 4 h after reperfusion, bile production in the AA-2G group was signiﬁcantly improved compared with that in the control group
(6.1±1.6 ml/h/100 g liver vs. 10.8±2.8 ml/h/100 g liver, P＜
0.05).
Fig. 2  The increase of AST levels 4 h after reperfusion in the AA-2G group were signiﬁcantly suppressed compared with those in the control group(4292±1401 vs. 6944±2143 IU/L, P＜0.05).
A  B 
Fig.3  Light micrographs of the liver graft, obtained 4 h after reperfusion, stained with H&E. (A)Control group:microvesicular vacuolation in the cytoplasm of the hepatocytes were observed. (B)AA-2G group:these vacuolations were not prominent. Bars indicate 50μm.
Table 1  The eﬀect of addition of AA-2G to UW solution on survival time
 
Survival(days) Mean Survival Time(days)
Control  5,5,5,6,6,7,12,18,20,25  10.9± 7.5 ?AA-2G  12,13,13,14,18,20,30,48,52,60  28.0±18.5
?P＜0.001
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 but PI negative, represent the fraction with early apoptosis (Quadrant 2). The cells that were both Annexin-V and PI positive showed the fraction with late apoptosis (Quadrant 3). The cells that were Annexin-V negative, but PI positive, demonstrated the fraction with necrosis(Quadrant 4). The ratio of viable hepatocytes in the AA-2G group was signiﬁcantly higher than that in the control group (93.4±2.0 vs. 80.3±2.1 , P＜0.005,
Table 2). The rates of early apoptotic and late apoptotic hepatocytes in the control group were 10.0±4.7 , and 6.4±1.7 , respectively, indicating that the main cell death of hepatocytes in the control group was apoptosis.
In contrast, both early and late apoptosis of the he-
patocytes was signiﬁcantly inhibited in the AA-2G group
(early apoptosis:0.98±0.88 , late apoptosis:2.2±1.1
). There was no signiﬁcant diﬀerence in the ratio of necrotic hepatocytes between the AA-2G group and control group(3.52±2.25 vs.2.76±0.99 ).
The expression of caspase 9 in the hepatocytes was observed in the control group(Fig. 5A). In contrast, the expression of caspase 9 in the hepatocytes was suppres-
sed in the AA-2G group(Fig. 5B).
Discussion
 
Controversy exists over whether the main cell death of hepatocytes after I/R injury is due to apoptosis or necrosis. As before, cold ischemia appears to cause injury mainly to sinusoidal endothelial cells (SEC), and also activates Kupﬀer cells, resulting in hepatocellular necrosis after reperfusion［23, 24］. In recent years,
several laboratories have reported evidence for apoptotic cell death during I/R injury［11, 12, 25］. According to these studies using the TUNEL assay, 50  to 70  of SEC and 40 to 60 of hepatocytes undergo apoptosis
 
Fig.4  Dual-parameter ﬂow cytograms of FITC-labeled Annexin V(abscissa)vs. PI staining(ordinate)of the control group(A)and the AA-2G group(B). Viable hepatocytes were negative for both Annexin V and PI(quadrant 1);Early apoptotic hepatocytes were labeled by Annexin V,
while being negative for PI(quadrant 2);Late apoptotic hepatocytes were positive for both Annexin V and PI(quadrant 3);Necrotic hepatocytes were labeled by PI, while being negative for Annexin V(quadrant 4). The percentages of hepatocytes in quadrant 1 were 80.3±2.1% and 93.4±2.0% in the control group and AA-2G group, respectively, whereas those for early apoptotic hepatocytes in quadrant 2 were 10.0±
4.7% and 0.98±0.88%.
Table 2  The percentage of viable, early and late apoptosis hepatocytes 4 h after reperfusion analysed by ﬂow cytometry of Annexin V and PI staining.
Viable cell(%) Early apoptosis(%) Late apoptosis (%)
Control  80.3±2.0  10.0±4.7  6.4±1.7? ?? ???AA-2G  93.4±2.0  0.98±0.88  2.2±1.1
?P＜0.05, ??P＜0.005, ???P＜0.001
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 during reperfusion［11, 12］. In contrast, Gujral et al.
reported that only a small minority of SEC and he-
patocytes undergo apoptosis after warm I/R injury, as the result of using the Annexin V-based assay［14］.
Although the main cell death of hepatocytes after I/R injury might be inﬂuenced by both the phase after reper-
fusion and the preservation time［4, 6, 14］, we inves-
tigated the predominant cell death of hepatocytes after I/
R injury(24 h cold ischemia in UW solution and 4 h reperfusion)in rat liver transplantation, using the Annex-
in V-based assay.
The controversy about the causes of the main cell death of hepatocytes after I/R injury(apoptotic or ne-
crotic) might be inﬂuenced by the sensitivity of the methods used to detect apoptosis. Because the TUNEL assay detected the cleaved DNA fragments, which occur not only during apoptosis but also during necrosis, the TUNEL assay cannot be used to quantify apoptotic cell without supporting morphological evidence if the mode of cell death is in question［26, 27］. In contrast, the Annexin V assay can identify apoptosis, based on the detection of cell surface-exposed phosphotidyl serine,
because the externalization of phosphotidyl serine occurs in the earlier stages of apoptosis［14, 15, 22］. The exposure of phosphotidyl serine does not depend on the involvement of the nucleus, but requires the activation of caspase 3 and a Ca?ﬂux over the plasma membrane
［28］. Therefore, the Annexin V assay can detect apoptotic cells in various phases ranging from the early stage, in which no morphological changes of the nucleus are detected on the electron microscopy level, until the late stage, with a pyknotic nucleus and condensed cyto-
plasm［29］.
Ascorbic acid(AA), while it possesses strong antiox-
idative activity and reacts rapidly with many kinds of active oxygen and free radicals, is chemically unstable and easily oxidized by oxygen in aqueous solution or air［16,
17］. In contrast, AA-2G is chemically stable and is hydrolyzed to AA by tissueα-glucosidases［18-20］.
Thus, AA-2G can be applied to the additive agent for the preservation solution as a free radical scavenger. We set up the dose of additional AA-2G to the UW solution according to the eﬀective serum level of AA, to reverse the preexisting condition of scurvy animals［18］. In this study, the addition of AA-2G to the UW solution reduced the apoptosis of hepatocytes after 24 h cold ischemia/reperfusion injury, leading to the improvement of the survival time in rat liver transplantation.
In ischemia/reperfusion injury, hepatocytes are sub-
jected to oxidative stress induced by both ROS generated intracellularly in response to cytokines, and ROS produced extracellularly by inﬂammatory cells［30］.
Higher amounts of extracellular ROS can cause necrosis caused by the loss of plasma membrane integrity, where-
as low concentrations of extracellular ROS can only induce apoptosis［31, 32］. ROS produced intracellularly are known to act as intermediates in the apoptotic signa-
ling pathway［31, 33, 34］. Both intracellular and extracellular ROS elicites a rapid and massive cytochrome c release from mitochondria, resulting in the activation of caspase-9, followed by the activation of other caspases
［35］. In our study, the expression of caspase-9 in the liver graft was suppressed by the addition of AA-2G to the UW solution. Therefore, it was suggested that
 
A  B 
Fig.5  Immunohistochemical staining of caspase 9. (A)Control group. (B)AA-2G group. Bars indicate 100μm.
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adding AA-2G to the UW solution could reduce the apoptosis of hepatocytes after cold ischemia/reperfusion injury, not only by suppressing ROS production, but also by inhibiting cytochrome c release from mitochondria and subsequent activation of caspase-9 due to ROS.
In conclusion, our study using the Annexin V-based assay provides evidence that the predominant cell death of hepatocytes is due to apoptosis after 24 h cold ischemia/
reperfusion injury in rat liver transplantation. The addi-
tion of AA-2G to the UW solution suppressed the apoptosis of the hepatocytes after 24 h cold ischemia/
reperfusion injury by inhibiting the activation of the caspase pathway due to ROS, and contributed to the improvement of survival. AA-2G, which has chemical stability and a unique bioreactive nature, may thus be of great use in clinical liver transplantations.
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